Incyte (WBO:INCY) Cyclically Adjusted Book per Share: €11.97 (As of Mar. 2026)


WBO:INCY Incyte Corp WBO:INCY
87 GF Score
Price €70.36
GF Value €59.73
! 4 Warning Signs
View Full Analysis

What is Incyte Cyclically Adjusted Book per Share?

Incyte WBO:INCY 87 Cyclically Adjusted Book per Share is €11.97 as of Mar. 2026. GuruFocus rates WBO:INCY with a GF Score™ of 87/100 and a GF Value™ of €59.73. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Incyte's adjusted book value per share for the three months ended in Mar. 2026 was €24.325. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €11.97 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Incyte's average Cyclically Adjusted Book Growth Rate was 21.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 24.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 33.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Incyte was 80.80% per year. The lowest was -56.10% per year. And the median was 1.05% per year.

As of today (2026-07-09), Incyte's current stock price is €70.36. Incyte's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €11.97. Incyte's Cyclically Adjusted PB Ratio of today is 5.88.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Incyte was 1233.83. The lowest was 4.32. And the median was 12.51.


Incyte  (WBO:INCY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Incyte's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=70.36/11.97
=5.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Incyte was 1233.83. The lowest was 4.32. And the median was 12.51.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Incyte Cyclically Adjusted Book per Share Related Terms


Incyte Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Incyte's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Incyte Cyclically Adjusted Book per Share Chart

Incyte Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.10 6.80 11.50 12.75 10.73

Incyte Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.29 14.26 12.01 10.73 11.97

WBO:INCY vs INSM, BNTX, ROIV: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Incyte's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Incyte Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incyte's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Incyte's Cyclically Adjusted PB Ratio falls into.


WBO:INCY
87GF Score
Incyte Corp WBO:INCY
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Incyte Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Incyte's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=24.325/330.2130*330.2130
=24.325

Current CPI (Mar. 2026) = 330.2130.

Incyte Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.407 241.018 1.928
201609 1.751 241.428 2.395
201612 2.106 241.432 2.880
201703 4.415 243.801 5.980
201706 4.444 244.955 5.991
201709 6.989 246.819 9.350
201712 6.522 246.524 8.736
201803 6.231 249.554 8.245
201806 6.984 251.989 9.152
201809 7.262 252.439 9.499
201812 7.938 251.233 10.433
201903 8.612 254.202 11.187
201906 9.256 256.143 11.933
201909 10.213 256.759 13.135
201912 10.818 256.974 13.901
202003 8.083 258.115 10.341
202006 9.547 257.797 12.229
202009 9.273 260.280 11.765
202012 9.779 260.474 12.397
202103 10.421 264.877 12.992
202106 11.055 271.696 13.436
202109 12.117 274.310 14.586
202112 15.091 278.802 17.874
202203 15.842 287.504 18.195
202206 17.417 296.311 19.410
202209 19.190 296.808 21.350
202212 18.521 296.797 20.606
202303 18.686 301.836 20.443
202306 19.592 305.109 21.204
202309 20.619 307.789 22.121
202312 21.219 306.746 22.842
202403 22.102 312.332 23.367
202406 14.534 314.175 15.276
202409 14.820 315.301 15.521
202412 17.021 315.605 17.809
202503 17.507 319.799 18.077
202506 18.628 322.561 19.070
202509 20.205 324.800 20.542
202512 22.236 324.054 22.659
202603 24.325 330.213 24.325

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €11.97 mean?
Incyte (WBO:INCY) has a Cyclically Adjusted Book per Share of €11.97 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Incyte and its competitors.
Is Incyte's Cyclically Adjusted Book per Share too high?
Incyte's current Cyclically Adjusted Book per Share is €11.97. Overall, Incyte has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Incyte's Cyclically Adjusted Book per Share compare to INSM and BNTX?
Incyte's Cyclically Adjusted Book per Share of €11.97 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Incyte and its competitors. Incyte's current Cyclically Adjusted Book per Share is €11.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Incyte stock overvalued right now?
Incyte (WBO:INCY) has a current Cyclically Adjusted Book per Share of €11.97. The stock's GF Value™ is €59.73, compared to a current price of €70.36 — trading 17.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is €11.97. Incyte's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Incyte (WBO:INCY), the current Cyclically Adjusted Book per Share is €11.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Incyte (WBO:INCY) Overvalued in 2026?

Based on GuruFocus' analysis, Incyte stock appears to be overvalued. The current stock price of €70.36 is trading 17.8% above its estimated GF Value™ of €59.73.

Key valuation signals for WBO:INCY:

  • Cyclically Adjusted Book per Share: €11.97
  • GF Value™: €59.73 vs. price of €70.36 (17.8% above fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the WBO:INCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Incyte Business Description

Address 1801 Augustine Cut-Off, Wilmington, DE, USA, 19803
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.
87GF Score

Get the complete analysis for WBO:INCY

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€70.36
Price
€59.73
GF Value